| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Dyne-101 | Dyne101 | Phase 2 Clinical | Myotonic Dystrophy; Muscular Atrophy | Details | |
| ARO-DM1 | ARO-DM1 | Phase 2 Clinical | Arrowhead Pharmaceuticals Inc | Myotonic Dystrophy | Details |